109 related articles for article (PubMed ID: 19960790)
1. Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosis.
Luppi F; Losi M; D'Amico R; Fabbri LM; Richeldi L
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):64-8. PubMed ID: 19960790
[TBL] [Abstract][Full Text] [Related]
2. Inhaled Interferon and Diffusion Capacity in Idiopathic Pulmonary Fibrosis (IPF).
Skaria SD; Yang J; Condos R; Smaldone GC
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):37-42. PubMed ID: 26237354
[TBL] [Abstract][Full Text] [Related]
3. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.
King TE; Albera C; Bradford WZ; Costabel U; Hormel P; Lancaster L; Noble PW; Sahn SA; Szwarcberg J; Thomeer M; Valeyre D; du Bois RM;
Lancet; 2009 Jul; 374(9685):222-8. PubMed ID: 19570573
[TBL] [Abstract][Full Text] [Related]
4. Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis.
Diaz KT; Skaria S; Harris K; Solomita M; Lau S; Bauer K; Smaldone GC; Condos R
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):79-87. PubMed ID: 22360317
[TBL] [Abstract][Full Text] [Related]
5. Cytokine modulation in patients with idiopathic pulmonary fibrosis undergoing treatment with steroids, immunosuppressants, and IFN-γ 1b.
Marinari S; De Iuliis V; Dadorante V; Colella S; Marino A; Nunziata A; Flati V; Caruso M; Pennelli A; De Benedetto F; Matera S; Capodifoglio S; Martinotti S; Caputi S; Toniato E
J Biol Regul Homeost Agents; 2017; 31(1):59-69. PubMed ID: 28337871
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis.
Nathan SD; Barnett SD; Moran B; Helman DL; Nicholson K; Ahmad S; Shorr AF
Respiration; 2004; 71(1):77-82. PubMed ID: 14872115
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Fibrosis Treated with Inhaled Interferon-gamma (IFN-γ).
Fusiak T; Smaldone GC; Condos R
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):406-10. PubMed ID: 26327351
[TBL] [Abstract][Full Text] [Related]
8. Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis.
Strieter RM; Starko KM; Enelow RI; Noth I; Valentine VG;
Am J Respir Crit Care Med; 2004 Jul; 170(2):133-40. PubMed ID: 15044205
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.
Antoniou KM; Nicholson AG; Dimadi M; Malagari K; Latsi P; Rapti A; Tzanakis N; Trigidou R; Polychronopoulos V; Bouros D
Eur Respir J; 2006 Sep; 28(3):496-504. PubMed ID: 16611657
[TBL] [Abstract][Full Text] [Related]
10. Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis.
Tzortzaki EG; Antoniou KM; Zervou MI; Lambiri I; Koutsopoulos A; Tzanakis N; Plataki M; Maltezakis G; Bouros D; Siafakas NM
Respir Med; 2007 Aug; 101(8):1821-9. PubMed ID: 17391951
[TBL] [Abstract][Full Text] [Related]
11. Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b.
Antoniou KM; Tzortzaki EG; Alexandrakis MG; Zervou M; Tzanakis N; Sfiridaki K; Bouros DE; Siafakas NM
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):204-9. PubMed ID: 16315783
[TBL] [Abstract][Full Text] [Related]
12. Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients.
Antoniou KM; Tzanakis N; Tzortzaki EG; Malagari K; Koutsopoulos AV; Alexandrakis M; Wells AU; Siafakas NM
Pulm Pharmacol Ther; 2008 Dec; 21(6):840-4. PubMed ID: 18644457
[TBL] [Abstract][Full Text] [Related]
13. Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?
Prasse A; Müller KM; Kurz C; Hamm H; Virchow JC
Eur Respir J; 2003 Dec; 22(6):906-11. PubMed ID: 14680077
[TBL] [Abstract][Full Text] [Related]
14. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
King TE; Albera C; Bradford WZ; Costabel U; du Bois RM; Leff JA; Nathan SD; Sahn SA; Valeyre D; Noble PW
Am J Respir Crit Care Med; 2014 Apr; 189(7):825-31. PubMed ID: 24476390
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.
Ziesche R; Hofbauer E; Wittmann K; Petkov V; Block LH
N Engl J Med; 1999 Oct; 341(17):1264-9. PubMed ID: 10528036
[TBL] [Abstract][Full Text] [Related]
16. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.
King TE; Safrin S; Starko KM; Brown KK; Noble PW; Raghu G; Schwartz DA
Chest; 2005 Jan; 127(1):171-7. PubMed ID: 15653980
[TBL] [Abstract][Full Text] [Related]
17. Serum CA 15-3 is increased in pulmonary fibrosis.
Ricci A; Mariotta S; Bronzetti E; Bruno P; Vismara L; De Dominicis C; Laganà B; Paone G; Mura M; Rogliani P; Mastrangeldo M; Sciacchitano S; Saltini C
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):54-63. PubMed ID: 19960789
[TBL] [Abstract][Full Text] [Related]
18. Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).
Antoniou KM; Alexandrakis MG; Sfiridaki K; Tsiligianni I; Perisinakis K; Tzortzaki EG; Siafakas NM; Bouros DE
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):105-10. PubMed ID: 15281431
[TBL] [Abstract][Full Text] [Related]
19. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis.
Costabel U; Albera C; Bradford WZ; Hormel P; King TE; Noble PW; Sahn SA; Valeyre D; du Bois RM
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):198-205. PubMed ID: 25363219
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.
Markart P; Nass R; Ruppert C; Hundack L; Wygrecka M; Korfei M; Boedeker RH; Staehler G; Kroll H; Scheuch G; Seeger W; Guenther A
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):161-72. PubMed ID: 20109123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
